SCHEMBL352004

SCHEMBL352004

CC(C)CCCCCCCCCCCCCCCCO

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
ALDH1A1 P00352 3/20 0.45
TSHR P16473 2/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.40
TRPV1 Q8NER1 1/20 0.38
TRPA1 O75762 1/20 0.38
KDM4C Q9H3R0 2/20 0.36
KDM4A O75164 1/20 0.36
PHF8 Q9UPP1 1/20 0.36
KDM2A Q9Y2K7 1/20 0.36
BLM P54132 1/20 0.36
PTPN1 P18031 1/20 0.35
GBA1 P04062 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14839871 1.00 LMNA (0.50) LMNAALDH1A1TSHRHSD17B10MEN1
Isostearyl Alcohol SCHEMBL8716 1.00 LMNA (0.50) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL9620428 1.00 LMNA (0.50) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL3778363 1.00 LMNA (0.50) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL26877 1.00
SCHEMBL2201832 1.00 LMNA (0.50) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL20345 1.00 LMNA (0.50) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL5498280 1.00 LMNA (0.50) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL852700 1.00 LMNA (0.50) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL19468481 1.00 LMNA (0.50) LMNAALDH1A1TSHRHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8603449-B2 Rinse-off conditioning composition comprising a near-terminal branched alcohol THE PROCTER & GAMBLE COMPANY (US) 2013-12-10 US claimed
EP-2593073-A2 RINSE-OFF CONDITIONING COMPOSITION COMPRISING A NEAR-TERMINAL BRANCHED ALCOHOL The Procter and Gamble Company (US) 2013-05-22 EP claimed
US-20120014901-A1 Rinse-Off Conditioning Composition Comprising a Near-Terminal Branched Alcohol THE PROCTER & GAMBLE COMPANY 2012-01-19 US claimed
WO-2012009522-A2 RINSE-OFF CONDITIONING COMPOSITION COMPRISING A NEAR-TERMINAL BRANCHED ALCOHOL THE PROCTER & GAMBLE COMPANY (US) 2012-01-19 WO claimed
CN-117545826-B Viscosity index improver, refrigerator oil, and working fluid composition for refrigerator 三洋化成工业株式会社 2026-05-15 CN disclosed
CN-115667599-B Heat storage composition 住友化学株式会社 2026-05-12 CN disclosed
US-12576086-B2 Aqueous composition, in particular for treating mucosa and/or wounds B. BRAUN MELSUNGEN AG (DE) 2026-03-17 US disclosed
EP-4695321-A1 VINYL ACETATE HAVING LOW DEUTERIUM CONTENT BASF SE (DE) 2026-02-18 EP disclosed
US-12552889-B2 Viscosity index improver, refrigerator oil, and working fluid composition for refrigerators SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2026-02-17 US disclosed
US-12509818-B2 Synthetic fiber processing agent, and synthetic fiber TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) 2025-12-30 US disclosed
US-12492280-B2 Process for producing a polyurethane composition BASF SE (DE) 2025-12-09 US disclosed
US-20250361405-A1 COMPOSITION BASED ON A POLYMERIZABLE COMPONENT AND A THIXOTROPIC ADDITIVE ARKEMA FRANCE (FR) 2025-11-27 US disclosed
US-5597846-A ESTERS OF RADICICOL SANKYO COMPANY, LIMITED (JP) 1997-01-28 US disclosed
US-5559109-A Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist SANKKO COMPANY, LIMITED (JP) 1996-09-24 US disclosed
US-5556852-A PLATELET ACTIVATING FACTOR ANTAGONISTS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0395446-B1 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists SANKYO CO (JP) 1995-03-01 EP disclosed
US-5369106-A N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists SANKYO COMPANY, LIMITED (JP) 1994-11-29 US disclosed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US disclosed
WO-1991018905-A1 RADICICOL DERIVATIVES, THEIR PREPARATION AND THEIR ANTI-TUMOR ACTIVITY SANKYO COMPANY LIMITED (JP) 1991-12-12 WO disclosed
EP-0460950-A1 Radicicol derivatives, their preparation and their anti-tumour activity Sankyo Company Limited (JP) 1991-12-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552889-B2 Viscosity index improver, refrigerator oil, and working fluid composition for refrigerators F12, BCL2A1, C1R LMNA 1584/4885ALDH1A1 2036/4885TSHR 1422/4885
US-12509818-B2 Synthetic fiber processing agent, and synthetic fiber SMCHD1, HACD2, SMC2 LMNA 706/4885ALDH1A1 4300/4885TSHR 2797/4885
US-20120014901-A1 Rinse-Off Conditioning Composition Comprising a Near-Terminal Branched Alcohol ITGB7, ARG1, ITGB1 LMNA 296/4885ALDH1A1 894/4885TSHR 3671/4885
US-12576086-B2 Aqueous composition, in particular for treating mucosa and/or wounds FABP2, SCNN1B, AQP3 LMNA 730/4885ALDH1A1 1460/4885TSHR 2793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.